Related Experiment Video
Updated: Apr 12, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Membranoproliferative glomerulonephritis associated with an Epstein-Barr virus infection
Lazarus Karamadoukis1, Tibor Toth2, Charlie Tomson1
1The Richard Bright Renal Unit.
Abstract:
Type 1 membranoproliferative glomerulonephritis (MPGN) is an immune complex-mediated disorder that has been associated with certain viral infections including hepatitis C, hepatitis B, hepatitis G, HIV and Hantavirus. We describe a patient with type 1 MPGN in native kidneys and nephrotic syndrome in whom there was strong evidence that a primary Epstein-Barr virus (EBV) infection played a causative role. This patient was treated with an angiotensin 2-receptor blocker and the nephrotic syndrome resolved within 6 months from presentation. Our case report suggests that MPGN presenting with nephrotic syndrome may have a relatively benign course when it is associated with an acute EBV infection.
Insights
Type 1 membranoproliferative glomerulonephritis (MPGN) linked to Epstein-Barr virus (EBV) infection can present with nephrotic syndrome. Treatment with an angiotensin 2-receptor blocker led to resolution, suggesting a potentially benign course for EBV-associated MPGN.
Area of Science:
- Nephrology
- Virology
- Immunology
Background:
- Type 1 membranoproliferative glomerulonephritis (MPGN) is an immune complex-mediated kidney disease.
- MPGN has been associated with various viral infections like hepatitis C, B, G, HIV, and Hantavirus.
Purpose of the Study:
- To report a case of type 1 MPGN with nephrotic syndrome potentially caused by a primary Epstein-Barr virus (EBV) infection.
- To investigate the clinical course and treatment outcome of EBV-associated MPGN.
Main Methods:
- Case report describing a patient with type 1 MPGN and nephrotic syndrome.
- Clinical evaluation, evidence of primary EBV infection, and treatment with an angiotensin 2-receptor blocker.
Main Results:
- The patient presented with type 1 MPGN in native kidneys and nephrotic syndrome.
- Strong evidence suggested a primary Epstein-Barr virus (EBV) infection as the causative agent.
- Nephrotic syndrome resolved within six months of treatment with an angiotensin 2-receptor blocker.
Conclusions:
- Acute Epstein-Barr virus (EBV) infection may play a causative role in type 1 MPGN presenting with nephrotic syndrome.
- MPGN associated with acute EBV infection may follow a relatively benign clinical course with appropriate treatment.
Related Concept Videos
Cytomegalovirus Disease
Nephrotic Syndrome I : Introduction
Viral Meningitis

